# ORATOR (NCT01590355)

> A Phase II Randomized Trial for Early-stage Squamous Cell Carcinoma of the Oropharynx: Radiotherapy vs Trans-oral Robotic Surgery (ORATOR)

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01590355
- Phase: PHASE2
- Status: UNKNOWN
- Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Conditions: Early-Stage Squamous Cell Carcinoma of the Oropharynx
- Interventions: Radiotherapy; Transoral Robotic Surgery + Neck Dissection
- Enrollment: 68
- Primary outcome: Quality of Life

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 36
- YouTube: 2
- Podcasts: 1

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=orator-nct01590355

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT01590355", "email": "<work email>"}; the inbox owner confirms by the emailed link.